Quantifying the duration of pre-diabetes

被引:69
作者
Bertram, Melanie Y. [1 ]
Vos, Theo [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Ctr Burden Dis & Cost Effectiveness, Herston, Qld 4006, Australia
基金
英国医学研究理事会;
关键词
pre-diabetes; duration; epidemiology; screening; IMPAIRED FASTING GLUCOSE; LIFE-STYLE; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; MORTALITY; TOLERANCE; RISK; CRITERIA; OBESITY; AUSDIAB;
D O I
10.1111/j.1753-6405.2010.00532.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Interventions for individuals with pre-diabetes are efficacious, however, identification of people with pre-diabetes does not occur in Australia. This study aims to calculate the duration of pre-diabetes, in order to provide supporting evidence for a screening program. Methods: We carried out a systematic review and random effects meta-analysis to identify if an increased risk of mortality is present in people with pre-diabetes. The result of this meta-analysis as well as information on prevalence, remission of pre-diabetes and transition to diabetes from an Australian cohort study, were used in the software program DisMod to calculate duration. Results: From 2,578 articles identified, 11 studies met the inclusion criteria. The pooled relative risk of all-cause mortality was 1.26 (1.17-1.34) with no sign of heterogeneity between the studies. The average duration of pre-diabetes was 8.5 years in males aged 30+ and 10.3 years in females aged 30+. Conclusions: The duration of pre-diabetes in Australia is long enough to warrant a screening program. The finding is robust to sensitivity testing of very large variations in the epidemiological parameters. Implications: If the interventions following screening are shown to be cost-effective, a strong rationale for the implementation of a screening program exists.
引用
收藏
页码:311 / 314
页数:4
相关论文
共 20 条
  • [1] [Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
  • [2] [Anonymous], LANCET
  • [3] Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose:: more results from the Paris Prospective Study
    Balkau, B
    Forhan, A
    Eschwège, E
    [J]. DIABETOLOGIA, 2002, 45 (09) : 1224 - 1230
  • [4] A generic model for the assessment of disease epidemiology: The computational basis of DisMod II
    Jan J Barendregt
    Gerrit J van Oortmarssen
    Theo Vos
    Christopher JL Murray
    [J]. Population Health Metrics, 1 (1)
  • [5] Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
    Barr, Elizabeth L. M.
    Zimmet, Paul Z.
    Welborn, Timothy A.
    Jolley, Damien
    Magliano, Dianna J.
    Dunstan, David W.
    Cameron, Adrian J.
    Dwyer, Terry
    Taylor, Hugh R.
    Tonkin, Andrew M.
    Wong, Tien Y.
    McNeil, John
    Shaw, Jonathan E.
    [J]. CIRCULATION, 2007, 116 (02) : 151 - 157
  • [6] Barr ELM., 2006, AusDiab 2005 The Australian diabetes
  • [7] de Rezende J, 1965, Rev Ginecol Obstet (Sao Paulo), V117, P23
  • [8] DER PRADIABETES
    DITSCHUNEIT, H
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1965, 90 (43) : 1925 - +
  • [9] The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates
    Dunstan, DW
    Zimmet, PZ
    Welborn, TA
    Cameron, AJ
    Shaw, J
    de Courten, M
    Jolley, D
    McCarty, DJ
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) : 119 - 129
  • [10] Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
    Gillies, Clare L.
    Abrams, Keith R.
    Lambert, Paul C.
    Cooper, Nicola J.
    Sutton, Alex J.
    Hsu, Ron T.
    Khunti, Kamlesh
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7588): : 299 - 302B